Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Roche Holding AG Business Biotech and Pharmaceuticals
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags US: News Eli Lilly and Co Breaking news
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Biotech and Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Health & Science Novo Nordisk A/S Johnson & Johnson
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Novo Nordisk A/S Health & Science Health care industry
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Biotech and Pharmaceuticals Business Roche Holding AG
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Healthy Returns Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Biotech and Pharmaceuticals Healthy Returns Health care industry
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Health & Science Biotechnology Novo Nordisk A/S
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock markets Investment strategy Business News
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Cigna Corp Politics Sanofi SA
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Market Outlook World Markets Interest Rates
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Goldman Sachs Group Inc Markets Daily Open
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Science Weight management Prescription drugs
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Deutsche Bank AG Biotech and Pharmaceuticals US: News
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Healthy Returns Eli Lilly and Co Cigna Corp
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Novo Nordisk A/S Health & Science Zealand Pharma A/S
From CNBC.com News
5 things to know before the stock market opens
Tags Economy NVIDIA Corp 5 Things to Know
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags US: News Europe News Asia News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Biotechnology Novo Nordisk A/S Health & Science
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Pharmaceuticals Breaking News: Markets Europe News
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Labor economy Health care industry Social issues
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Pharmaceuticals Business News Companies
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Europe Markets Prices Novo Nordisk A/S
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Personal finance Employee benefits Obesity
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Breaking news Companies Business News
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Novo Nordisk A/S Investing Investment strategy
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Novo Nordisk A/S Zealand Pharma A/S Personal investing
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Hospitals Teladoc Health Inc Breaking News: Technology
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Biotech and Pharmaceuticals Healthy Returns Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.